Switch to:
More From Other Websites
Some Pharma Stocks Trade below All Moving Averages in Early August Aug 25 2015
Alkermes' (ALKS) Aristada Review Date Postponed by FDA Aug 24 2015
ALKERMES PLC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 21 2015
Alkermes Provides Update on FDA Review of ARISTADA™ for the Treatment of Schizophrenia Aug 21 2015
Alkermes Provides Update on FDA Review of ARISTADA™ for the Treatment of Schizophrenia Aug 21 2015
Alkermes Provides Update on FDA Review of ARISTADA™ for the Treatment of Schizophrenia Aug 21 2015
3 Key Biotech Drug Approvals Expected This Month Aug 12 2015
Healthcare and Pharmaceuticals Prevail in Stable Market Conditions Aug 12 2015
5 Big FDA Decisions Expected in August Aug 06 2015
ALKERMES PLC. Financials Aug 05 2015
Alkermes' Reports Wider Q2 Loss, Increases Guidance - Analyst Blog Jul 31 2015
Edited Transcript of ALKS earnings conference call or presentation 30-Jul-15 12:30pm GMT Jul 30 2015
Alkermes reports 2Q loss Jul 30 2015
Alkermes reports 2Q loss Jul 30 2015
Alkermes Plc Earnings Call scheduled for 8:30 am ET today Jul 30 2015
ALKERMES PLC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 30 2015
Alkermes plc Reports Second Quarter 2015 Financial Results Jul 30 2015
Q2 2015 Alkermes Plc Earnings Release - Before Market Open Jul 30 2015
Alkermes plc Reports Second Quarter 2015 Financial Results Jul 30 2015
Alkermes plc Reports Second Quarter 2015 Financial Results Jul 30 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK